CCT2 is an aggrephagy receptor for clearance of solid protein aggregates

Xinyu Ma1, Caijing Lu1, Yuting Chen2

  • 1State Key Laboratory of Membrane Biology, Beijing, China; Tsinghua-Peking Center for Life Sciences, Beijing 100084, China; School of Life Sciences, Tsinghua University, Beijing 100084, China.

Cell
|April 2, 2022
PubMed

Insights

Researchers discovered CCT2 as a novel autophagy receptor. This protein selectively clears solid protein aggregates, offering new insights into neurodegenerative disease mechanisms.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Neuroscience

Background:

  • Protein aggregation is implicated in numerous human diseases.
  • Autophagy, specifically aggrephagy, is the cellular mechanism for degrading protein aggregates.
  • The precise mechanisms governing selective protein aggregate clearance by autophagy remain unclear.

Purpose of the Study:

  • To identify novel autophagy receptors involved in the selective degradation of protein aggregates.
  • To elucidate the mechanism by which CCT2 regulates aggrephagy.
  • To investigate the role of CCT2 in clearing aggregation-prone proteins in cellular and in vivo models.

Main Methods:

  • Identification of CCT2 as an autophagy receptor.
  • Analysis of CCT2 interaction with aggregation-prone proteins and ATG8s.
  • Assessment of CCT2's role in aggrephagy independently of other known receptors.
  • Investigation of CCT2's functional switch in response to protein aggregation.

Main Results:

  • CCT2 acts as an autophagy receptor that targets aggregation-prone proteins for clearance.
  • CCT2 binds to protein aggregates independently of ubiquitination and interacts with ATG8s via a VLIR motif.
  • CCT2 specifically degrades solid protein aggregates, distinct from the liquid condensate clearance by P62, NBR1, and TAX1BP1.
  • Accumulation of aggregation-prone proteins triggers CCT2's transition from a chaperone to an autophagy receptor.

Conclusions:

  • CCT2 is a novel autophagy receptor crucial for the selective clearance of solid protein aggregates.
  • CCT2's unique mechanism of action provides new therapeutic targets for protein aggregation diseases.
  • Understanding CCT2's role advances knowledge of aggrephagy and its implications in pathology.